Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema

NCT01574248 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

33

Enrollment

OTHER

Sponsor class

Stopped DSMC recommended discontinuation for futility and feasibility

Conditions

ACE Inhibitor-associated Angioedema

Interventions

DRUG: icatibant
OTHER: Placebo

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]